Delivery Order SPE2DB22D2009-SPE2DB25FL8ZH

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of the pharmaceutical product Bicillin L-A in 2 milliliter vials. The contract has a firm fixed price of $3,218.58 and an ultimate completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,200,000 units of Bicillin L-A, a prescription medication, at a firm fixed price of $172,962.92. The contract has an ultimate completion date of April 16, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $1,327.87 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a completion date of January 31, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of Bicillin L-A, a prescription medication, at a ceiling value of $8,937.10. The order has a firm fixed price and an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,200,000 units of 2 mL Bicillin L-A, a penicillin-based antibiotic. The contract has a firm fixed price of $1,690.81 and a period of performance through April 9, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,801.76, is for the delivery of 1,200,000 units of Bicillin L-A, a prescription antibiotic medication, with a completion date of April 30, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of Bicillin L-A 2ML injectables. The contract has a ceiling value of $2,350.50 and is a firm fixed price delivery order with a completion date of May 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,644.96, is for the delivery of 1,200,000 units of Bicillin L-A, a prescription antibiotic medication, to be completed by May 1, 2025. The contract is not set aside and was awarded on April 30, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,822.76, is for the delivery of 2,400,000 units of Bicillin L-A, a pharmaceutical product, with a performance period ending on April 29, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 1,200,000 units of Bicillin L-A, a prescription antibiotic medication, at a ceiling value of $1,270.43. The contract has a firm fixed price pricing type and an ultimate completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide essential medical commodities to support...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL8ZH
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,200,000 units of Bicillin L-A (2 mL) at a firm fixed price of $5,774.16. The order has an ultimate completion date of April 29, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) worth $999,999,999.00 with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is part of the company's broader role as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/28/25, 11:16 AM